health ETH Zurich Scientists Identify GRK2 as New Alzheimer's Target and Develop Inhibitor
Researchers at ETH Zurich discovered that inactive GRK2 enzyme aggregates impair mitochondria, driving Alzheimer's. A new compound, Compound 10, successfully slowed disease progression in mice.
